Foundations

Most of this site is organised by activity — how you sleep, how you train, what you eat. This page collects what doesn't sit inside any one of those and yet touches all of them. Some of it is the largest lever available: not smoking is the biggest preventable-mortality gain in modern medicine, and no amount of training or supplementation competes with it. Some of it is unglamorous and underrated, like the state of your gums, the air in your bedroom, or the iron you have quietly accumulated since adolescence. And some of it is a way of reading: how much of your lifespan is inherited, what order to work in, and what questions to ask of the next study that circulates.

What the evidence actually supports

Strong:

• Not smoking is the largest single lever here, by a wide margin — roughly 8 million deaths a year globally, about 1.2 million of them from second-hand exposure, and combustion is the part that matters rather than the nicotine molecule.^[1]
• Air pollution is the second-largest environmental killer, and there is no safe floor. Each 5 micrograms of fine particulate matter per cubic metre of long-term exposure tracks with about 13% higher death rates from natural causes — and the association held, and even steepened, below every current European, US and World Health Organization limit.^[2]
• Radon is the cheapest high-yield test on this page. It is the second leading cause of lung cancer after smoking, implicated in roughly 21,000 US deaths a year, with about 16% higher lung-cancer risk per 100 becquerels per cubic metre and no threshold below which it stops mattering. A test kit costs about what a restaurant meal does.^[3]
• Lead, cadmium and arsenic are established cardiovascular risk factors, not fringe concerns — the American Heart Association classifies them formally alongside the traditional ones. All three accumulate for years to decades, so the only lever is preventing intake.^[4]
• Treating gum disease pays off in two places, and neither is the cardiovascular one people expect. In people with diabetes it lowers long-term blood sugar by about 0.4 percentage points of HbA1c, comparable to adding a second oral diabetes drug — pooled across randomised trials at moderate certainty, and with the single largest trial finding no benefit at all.^[5] The one genuinely hard endpoint in the field is elsewhere: in frail older adults in hospitals and care homes, daily mouth care prevents pneumonia, with roughly one case avoided for every 9 to 15 people cared for.^[6]
• Cumulative apolipoprotein B (apoB) exposure causes atherosclerosis. Not one panel reading — the lifetime number of cholesterol-carrying particles the artery wall has been exposed to.
• Composite lifestyle scores predict how long you live. In the Framingham Offspring cohort, adults scoring above the median on the American Heart Association's eight-component score had roughly 45% lower mortality over the following three decades, and about half the rate of cardiovascular events, than those below it.^[7]
• Fitness is the single most replicated predictor of the lot. Each one-unit increase in cardiorespiratory fitness — one metabolic equivalent, or 3.5 mL of oxygen per kilogram of body weight per minute — tracks with 11–17% lower all-cause mortality across 199 cohorts, though the underlying data are observational throughout and the authors grade that certainty very low to moderate.^[8] The detail lives in Exercise.

Moderate:

• Social connection is one of the largest non-pharmacological mortality signals in epidemiology — a 148-cohort meta-analysis puts strong relationships at roughly 50% higher survival odds. See Purpose and social connection below.
• Air pollution is now on the modifiable-dementia list. Pooling 32 studies covering some 26 million people, each 5 micrograms of fine particulate matter per cubic metre tracked with about 8% higher dementia incidence; certainty is limited by wide disagreement between studies and by how hard socioeconomic confounding is to remove.^[9]
• Resting heart rate is the cheapest useful biomarker available — see Resting heart rate below. A robust marker, and a poor lever: lowering it with a drug helps in heart failure, does nothing in coronary disease without heart failure, and has never been tried in healthy adults.
• Reducing exposome load moves the biomarkers. The randomised PERTH trial removed plastic touchpoints from food and personal care and cut urinary bisphenol A by 59.7% and two phthalate metabolites by 53.5% and 37.5%, at unchanged energy intake.^[10] These are exposure biomarkers, not outcomes.
• Periodontal treatment lowers systemic inflammation — professional gum cleaning drops C-reactive protein by roughly 0.6–0.8 mg/L, comparable to a statin or an intensive lifestyle programme, and heaviest in those with the worst gums to start. The landmark trial of the vascular side found arterial function transiently worsened for 24 hours before improving over two to six months.^[11]

Weak / preliminary:

• Purpose in life as a causal lever. The association with dementia and mortality is modest but well replicated — on the order of 15–17% lower risk — and the direction of the arrow is unsettled: a 16-year analysis of US cohort data found declining health driving declining purpose, with declining purpose predicting no later health decline, though its authors note that null may be under-powered for slow-developing conditions. No trial has shown that raising purpose extends life.
• The oral–cardiovascular link as causation. The observational association is strong, but genetic causal analysis comes up empty and the American Heart Association's 2025 position is that the evidence does not support causality.
• Iron reduction as therapy. The genetic case that lifetime iron burden shortens life is stronger than any treatment case — a phlebotomy trial was null, and both brain-iron-lowering trials made outcomes worse.
• Blue Zone demography. The behavioural patterns hold up better than the supercentenarian records do — it is the 110-plus tail that is fragile, not every age claim.

Caution:

• Supplemental iron without a documented deficiency. The body has no route to excrete it, so high-normal stores are a risk signal rather than a safety margin. The reverse error is at least as common, though: anaemia affects about one in ten people over 65 and more than one in five past 85, and in an older adult a low iron reading is a reason for a work-up — it can flag bleeding or malignancy — not a reason to self-treat.
• Nicotine outside a cessation context. Vapes are not a safe baseline — endothelial dysfunction and cardiovascular signals are documented — oral pouches are essentially unstudied long-term, and no form is considered safe in pregnancy.
• Chelation and "detox" protocols outside diagnosed poisoning. The definitive test is in: a 1,000-patient randomised trial of EDTA chelation in high-risk heart-attack survivors genuinely lowered blood lead and still did not reduce cardiovascular events.^[12] Chelation carries real harms — low blood calcium, kidney injury, reported deaths.

Topics covered in depth

Smoking and nicotine →

The largest preventable-mortality lever in modern medicine, and how the picture changes once you separate the combustion from the molecule. Accelerated epigenetic aging that partly reverses on cessation, the muscle-wasting machinery it switches on, and the hierarchy from combustible tobacco through vapes and pouches to the patch.

Oral health →

The oral–systemic axis: gum disease as a systemic inflammatory state, the tongue bacteria that supply much of the body's nitric oxide after midlife, why the strongest antiseptic mouthwashes are a double-edged tool, and why the cardiovascular link looks associational while the diabetes and pneumonia benefits are real.

Environmental toxins → · Iron and aging →

The external exposome and the internal one. Which chemicals clear in days and which linger for years, what actually lowers the load — a bedroom filter, a fragrance audit, a radon test — and why a metal you cannot excrete accumulates into a modifiable risk.

Cholesterol and lipoproteins →

Heart disease is the single biggest barrier to a long life, and what ages arteries is not one panel reading but the lifetime number of cholesterol-carrying particles they have been exposed to — the best worked example on this site of why apparent paradoxes usually aren't.

Resting heart rate →

The cheapest measurement on this site, and its clearest worked example of a marker that is not a lever. What a million people's worth of cohort data actually shows, why the textbook 60–100 range tells you almost nothing about yourself, and what happened in the three trials that lowered it on purpose.

Heart rate variability →

The most trackable physiological aging proxy available, what it does and doesn't tell you, and which wearables actually measure it.

Purpose and social connection →

Why the association is one of the largest in epidemiology, why late midlife looks like the window that matters, and why the effect is much harder to prove than to observe.

Blue Zones →

What survives scrutiny and what doesn't. Sardinia's villages passed the highest tier of demographic age-checking — in a defence co-authored by one of the original discoverers, with disclosed conflicts. Okinawa's and Nicoya's advantages collapsed within a generation, and the same 2025 analysis concludes Okinawa no longer qualifies. The Adventist cohort at Loma Linda is a rigorous 96,000-person study with a 4–7 year advantage, up to around 10 among its vegetarians, though it sits outside the peer-reviewed blue-zone set. The supercentenarian claims and the certification business are a different matter again.

Inherited vs. modifiable

Estimates of how much of the variation in lifespan is set by inherited gene variants cluster around 20–30%,^[13] with some large pedigree studies as low as 6%. That twenty-to-thirty-percent band is the most-quoted number in the field, and it is contested from the other direction too: a 2026 reanalysis argues the twin estimates are deflated by extrinsic deaths — accidents, infections — and that the heritability of intrinsic ageing is above 50% once those are stripped out.^[14] The honest range is wide, and this site does not pick a number.

It matters less than it looks, because the practical conclusion survives either estimate. The clearest test so far comes from dementia: in a large randomised trial of a multi-part lifestyle programme, the benefit was statistically indistinguishable between carriers and non-carriers of the APOE ε4 variant that raises Alzheimer's risk. Because carriers start from higher baseline risk, the usual inference is that they stand to gain more in absolute terms — a reasonable assumption the data are consistent with, rather than something the trial demonstrated. See Dementia prevention. Behaviour dominates the advice here because it is the part you can change, not because genes are negligible.

Whatever its exact size, the non-genetic share has two large components. One is lifestyle — what you eat, how you move, how you sleep, who you spend time with. The other is the exposome, the cumulative non-genetic input from air, water, household chemicals, and psychosocial stress. Specific chemicals — cadmium, lead, phthalates, bisphenols, and the perfluoroalkyl "forever chemicals" — measurably accelerate epigenetic-aging clocks at population scale, and substitution can drop urinary biomarkers of the non-persistent ones within weeks. See Environmental toxins. A subtler internal exposure works the same way: because the body has no route to excrete iron, it accumulates over a lifetime and catalyses oxidative damage. See Iron and aging.

Measuring what matters

A short list of readouts that earn their place, in rough order of cost.

Resting heart rate is the cheapest and most replicated. Across more than a million people, mortality rises roughly 9–17% for every 10 beats per minute, and it is not simply a proxy for being unfit — the association survives adjustment for directly measured fitness. It is also the site's clearest case of a marker that is not a lever: the trials that lowered it deliberately helped only in heart failure. What is worth measuring is your own trend, not a single reading against a population range. See Resting heart rate.

Heart rate variability — the millisecond fluctuation between heartbeats — is a non-invasive, continuously trackable read on how well the nervous system is regulating the body. It declines with age and tracks inflammation, metabolic dysfunction, and resilience. It is a robust risk marker; whether deliberately raising it extends life is unproven, and wearables vary widely in how well they measure it. See Heart rate variability.

ApoB is the one lipid number worth learning. It counts the atherogenic particles directly rather than the cholesterol inside them, and the gap between the two is wider than most people expect — though whether everyone needs it measured, rather than just the people whose standard panel is ambiguous, is still argued. See Cholesterol and lipoproteins for the biology and Lipid management for what to do about a given result.

Lipoprotein(a) is the one test to run once and never again. About one in five people inherit a high level; it is set genetically, stable from childhood, and essentially unmoved by diet, exercise, weight loss or statins — so it is invisible both to a lifestyle plan and to a standard panel, and a single measurement tells you whether you are carrying it. If it is high, the response for now is to push harder on everything else that is modifiable.

A radon test belongs on this list even though it measures your house rather than your body. It is a one-off, costs about as much as a meal out, and is the only item here where a bad result has a cheap engineering fix.

For the epigenetic clocks and the rest of the biological-age apparatus, see The Biology of Aging.

The behavioural hierarchy

The interventions that move biological-age biomarkers in healthy adults are stubbornly the same ones that move hard cardiovascular and mortality endpoints. The American Heart Association consolidated them in 2022 as Life's Essential 8: diet, physical activity, nicotine avoidance, sleep, body mass index, blood lipids, blood glucose, and blood pressure, each scored 0–100.^[15] Adults scoring above the median on that composite had roughly 45% lower mortality over three decades in the Framingham Offspring cohort.^[16] A caveat that the score's marketing tends to omit: it predicts mortality no better than the simpler seven-component version it replaced, and adding either to a conventional risk model buys only marginal accuracy.^[17] These composites are useful as a checklist of what to work on, not as a precision instrument.

A reasonable mental hierarchy for healthy midlife adults:

1. Remove the documented harms first. Smoking at zero, alcohol as near it as you can manage, sleep apnea screened rather than assumed, long motionless stretches broken up. See Smoking and nicotine.
2. Cardiorespiratory fitness and muscular strength. The largest and most replicated positive signal available, and larger than any pharmacological geroprotector — a drug proposed to target aging itself — currently in human trials. Meeting both the aerobic and the strength guidelines tracks with about 40% lower mortality, against 29% for aerobic work alone and 11% for strength work alone.^[18] See Exercise.
3. A vegetable- and fish-heavy dietary pattern (Mediterranean, MIND), optionally paired with time-restricted eating in a window that ends before late evening. See Nutrition.
4. Sleep regularity, at least as predictive of mortality as duration. In 60,977 UK Biobank adults with a week of wrist-accelerometer data, the most regular fifth had 48% lower all-cause mortality than the least regular — an advantage that falls to 30% once socioeconomic position, lifestyle and existing health are accounted for.^[19] See Sleep.
5. Social connection. A 148-cohort meta-analysis puts strong relationships at roughly 50% higher survival odds — one of the largest non-pharmacological mortality signals in epidemiology — and it is also the strongest single late-life protective marker for dementia, roughly 30% lower risk against about 9% for cognitive activity. See Cognitive engagement. Purpose travels with it and belongs here, with a much wider hedge: the observational signal is real but modest, the critical window looks like late midlife, some of it runs backwards — poor health drains purpose — and no trial has shown that raising purpose extends life. See Purpose.
6. Clean up the air and water you live in. A bedroom air filter, a radon test, cooking on a vented extractor, fewer scented products, decent water filtration, glass and steel out of food contact. Individually small, cheap, and the only category on this list where the dose-response has no safe floor. See Environmental toxins.
7. Controlled heat and cold. Regular sauna carries the largest mortality association of any wellness habit — but essentially all of it comes from one Finnish cohort, the only large independent cohort tested dementia rather than mortality and found about a third the effect, and twenty pooled randomised trials of passive heating found nothing on artery function, stiffness, glucose, lipids or inflammation. Blood pressure moved only in whole-body heating and in people who already have cardiovascular risk. Cold exposure has less evidence still, and is not the low-risk twin of a sauna: drowning is the leading cause of cold-water immersion death, and arrhythmia, cold urticaria and pregnancy are contraindications. Worth doing if you enjoy it; not a lever on the order of the five above. See Sauna, Cold exposure.

The pharmacological frontier sits below all of this for healthy adults, and is thinner than its coverage suggests. TAME, the metformin trial usually cited as the field's flagship, has never been funded or enrolled — it is a proposal, not a study in progress. PEARL, the first randomised trial of intermittent rapamycin in healthy adults, missed its primary endpoint and used a compounded drug at about a third the bioavailability of the generic. Senolytics — drugs that clear worn-out cells — are a live research area with one concrete reason for healthy adults to stay out of it: in a 19-person study, six months of the best-known combination accelerated several epigenetic-aging clocks in healthy volunteers — an effect that mostly faded by six months and never appeared on the two clocks best validated against health outcomes, but that is enough to say a tool built to clear sick cells can stress healthy ones. See Geroprotectors and Clinical Care.

For the full ordered action list drawn from every pillar, see the healthspan long list.

How to evaluate a "longevity intervention"

Most of what circulates as longevity advice is mechanistic plausibility dressed as clinical evidence. A short filter for reading any new claim:

1. What's the evidence type? Animal data alone has very weak human applicability. A biomarker moved in humans is suggestive but unproven. A randomised controlled trial with a hard endpoint is the gold standard. Mendelian randomization — which uses inherited genetic variants as a natural experiment — supports strong causal inference, and frequently deflates observational claims.
2. Who funded the study? A large share of the positive longevity-supplement literature rests on short industry-funded trials, and the funder's interest is worth knowing before the effect size is.
3. Is the population relevant? A signal in 80-year-olds with muscle wasting may not generalise to a healthy 45-year-old.
4. What's the absolute effect size? A "30% relative risk reduction" of a rare event is small in absolute terms. Lifestyle interventions usually beat supplements once the numbers are stated as cases avoided rather than percentages.
5. What's the alternative? Sometimes the best intervention is removing a harm — smoking, ultra-processed food, untreated sleep apnea — not adding a new one.

What's overrated

• Single-nutrient and single-molecule fixes. Pattern interventions — how you eat, move, and sleep across years — consistently outperform them.
• Composite health scores as precision instruments. Useful checklists; barely better than the simpler versions they replaced at predicting who dies.
• "Natural" as a safety claim. Iron, calcium and high-dose vitamins are all natural and all carry documented harm above a threshold.
• Detoxing. Chelation outside diagnosed poisoning failed its definitive trial and carries real harm; "detox" cleanses, juice fasts and anti-toxin supplement stacks have no outcome evidence in healthy adults. The exposures that matter are prevented at the source, not flushed out afterwards.
• Air-purifier theatre. Houseplants would need something like 10 to 1,000 per square metre of floor to match a basic mechanical filter, and plasma, ionizer and ultraviolet photocatalytic devices generate secondary pollutants — some produce more formaldehyde than they remove. A plain HEPA filter and an open window are the working version.
• Daily mouthwash for a healthy mouth. Chlorhexidine and high-alcohol rinses strip the tongue bacteria that supply much of the body's nitric oxide, with no matching benefit. Brushing and interdental cleaning are the intervention.
• Aggressive phlebotomy as anti-aging therapy. Offloading genuine overload is sensible; bleeding a healthy person toward deficiency is not, and the one large randomised test of the idea was null.
• Blue Zone mimicry as a programme. The behaviours validate independently; the certification business and the supercentenarian records do not, and copying a Sardinian diet without the village that came with it is copying the smaller half.
• Reading a single cholesterol panel as a verdict. Discordance between LDL cholesterol and apoB is larger than most people assume, and "my LDL is normal" is the most common way a real risk gets missed.
• Optimising markers you cannot act on. A number worth measuring is one where a specific different decision follows from a specific result.

---